Rhythm Pharmaceuticals stock surges 28% on AstraZeneca bid report

More in Finance

• Cramer: What must happen for Home Depot to keep its 25% monthlong rally going

  The home improvement giant's extended market advance into positive annual territory follows a broader housing sector rebound sparked by recent election outcomes, sliding bond yields, and falling oil prices. However, persistent headwinds from elevated mortgage rates continue to restrain residential renovation projects and overall consumer building activity across the sector.

  4 min read
• Prediction markets cement their status after forecasting Democratic sweep of Congress

  Real-time trading platforms anticipated a 54-seat Democratic Senate majority prior to the closure of polls on Tuesday. Driven by financially motivated traders who adjusted odds rapidly during vote counting, these exchanges beat established news networks to key race calls. The performance strengthens the case for wagering-based forecasting, though critics continue to warn of previous polling misses and broader regulatory risks.

  3 min read
• Goldman, Apollo seek buyers for $40 billion SpaceX AI chip deal, Bloomberg News reports

  Wall Street dealmakers are pitching large-scale participations ahead of formal syndication to fund substantial computing infrastructure for the aerospace company's technology initiatives. This multi-tranche setup relies on an off-balance-sheet equipment lease structure, positioning the transaction to become the largest GPU financing package ever recorded. The capital will secure massive processing hardware while protecting the rocket maker's core financial liabilities.

  1 min read